Sohanya Roshan Cheng, EVP & Chief Commercial Officer at Karyopharm Therapeutics Inc. (KPTI), sold 5,356 shares at $0.72 ($4K) on 2024-09-04, disclosed to the SEC on 2024-09-05.
Open-market sale of $4k KPTI by EVP & Chief Commercial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| KPTI | SELL | 2025-09-16 | $2K | — | Filing → |
| KPTI | SELL | 2025-03-06 | $22K | — | Filing → |
| KPTI | SELL | 2024-03-04 | $32K | — | Filing → |